Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luca Richeldi
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Treating Heart Failure With Preserved Ejection Fraction: Learning From Pulmonary Fibrosis
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Diagnosing Idiopathic Pulmonary Fibrosis in 2018: Bridging Recommendations Made by Experts Serving Different Societies
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
An Official European Respiratory Society/American Thoracic Society Research Statement: Interstitial Pneumonia With Autoimmune Features
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Paracrine Signalling During ZEB1-mediated Epithelial–mesenchymal Transition Augments Local Myofibroblast Differentiation in Lung Fibrosis
Cell Death and Differentiation
Cell Biology
Molecular Biology
Differing Severities of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (IPF): Insights From the INPULSIS® Trials
Respiratory Research
Pulmonary
Respiratory Medicine
The Characterisation of Interstitial Lung Disease Multidisciplinary Team Meetings: A Global Study
ERJ Open Research
Pulmonary
Respiratory Medicine
“Velcro-Type” Crackles Predict Specific Radiologic Features of Fibrotic Interstitial Lung Disease
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Efficacy and Safety of Nintedanib in Patients With Advanced Idiopathic Pulmonary Fibrosis
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Emerging Drugs for Idiopathic Pulmonary Fibrosis
Expert Opinion on Emerging Drugs
Pharmacology
1
2
›